Fundai

Kowsar Pharmaceutical Company (DKOSAR) cash flow statement

Operating, investing and financing cash flows, and the closing balance

Ticker
DKOSAR
Industry
Pharmaceuticals
Market
Tehran Stock Exchange

Latest periods

Latest 9-month periods, in million rials
ItemTo 1405/06/31To 1404/09/30To 1403/09/30To 1402/09/30To 1401/09/30To 1400/09/30
Cash generated from operations-4,380,504867,749144,25672,690140,796291,878
Cash payments for income tax-156,778-54,983-66,323-36,856-15,360-31,458
Net cash inflow (outflow) from operating activities-4,537,282812,76677,93335,834125,436260,420
Cash receipts from sale of property, plant and equipment69800000
Cash payments for purchase of property, plant and equipment-38,737-33,358-99,450-78,063-32,815-270,200
Cash receipts from sale of long-term investments4,660,2454,708,51250,019154,40000
Cash receipts from interest on other investments9061323564401,3721,297
Net cash inflow (outflow) from investing activities4,623,1124,594,497-236,389-125,068-44,694-281,899
Net cash inflow (outflow) before financing activities85,8305,407,263-158,456-89,23480,742-21,479
Cash receipts from facilities12,642,6335,465,4938,955,7664,468,0304,572,3863,873,888
Cash payments for principal of loans-11,144,241-8,339,359-6,817,458-3,662,784-4,215,093-3,609,194
Cash payments for interest on loans-1,136,705-1,764,886-1,550,604-531,056-306,828-366,893
Cash payments for dividends-53,936-88,280-33,437-654-7,125-64,078
Net cash inflow (outflow) from financing activities307,751-4,727,032554,267273,53643,340-166,277
Net increase (decrease) in cash393,581680,231395,811184,302124,082-187,756
Cash balance at beginning of year1,285,751606,779599,565540,24774,019411,178
Effect of changes in exchange rates45,055-1,25919,0342,4701,8590
Cash balance at end of year1,724,3871,285,7511,014,410727,019199,960223,422

Reporting periods

77 periods are on file for this report, from the period ending 1381/12/29 to the period ending 1405/06/31.